Idarucizumab for Reversal of Dabigatran: Single-Center Real-World Experience. [electronic resource]
Producer: 20190529Description: 59-64 p. digitalISSN:- 1179-187X
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Antidotes -- therapeutic use
- Antithrombins -- therapeutic use
- Atrial Fibrillation -- drug therapy
- Blood Coagulation -- drug effects
- Dabigatran -- therapeutic use
- Female
- Hemorrhage -- drug therapy
- Hemostasis -- drug effects
- Humans
- Intracranial Hemorrhages -- drug therapy
- Male
- Middle Aged
- Thrombosis -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.